What ICD‑10 code(s) correspond to major depressive disorder, recurrent episode, moderate‑to‑severe, with inadequate response to antidepressant monotherapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Code for Major Depressive Disorder, Recurrent Episode, Moderate-to-Severe, with Inadequate Response to Antidepressant Monotherapy

The appropriate ICD-10 code is F33.1 (Major depressive disorder, recurrent, moderate) or F33.2 (Major depressive disorder, recurrent, severe without psychotic features), depending on the specific severity assessment.

Understanding the ICD-10 Classification Structure

The ICD-10 coding system for recurrent major depressive disorder follows a hierarchical structure under the F33 category:

  • F33.0 - Recurrent depressive disorder, current episode mild
  • F33.1 - Recurrent depressive disorder, current episode moderate
  • F33.2 - Recurrent depressive disorder, current episode severe without psychotic symptoms
  • F33.3 - Recurrent depressive disorder, current episode severe with psychotic symptoms

Key Coding Considerations

Severity Determination

The distinction between moderate (F33.1) and severe (F33.2) is clinically significant and validated. Research demonstrates that ICD-10 severity grading predicts both relapse risk and suicide risk, with these outcomes increasing progressively from mild to moderate to severe episodes 1. This severity categorization should be preserved as it has proven clinical utility.

Treatment Response Status

Important caveat: ICD-10 does not have a specific code modifier for "inadequate response to antidepressant monotherapy" or treatment-resistant depression. The code reflects the current episode severity and recurrent nature, not the treatment response status.

According to consensus definitions, treatment-resistant depression (TRD) requires documentation of at least two failed antidepressant trials at adequate doses and duration within the current episode 2. However, this clinical descriptor does not change the base ICD-10 code—it remains F33.1 or F33.2 based on symptom severity.

Documentation Requirements

When coding for moderate-to-severe recurrent depression with inadequate treatment response:

  1. Select F33.1 or F33.2 based on current symptom severity using standardized assessment tools (HAM-D scores: 18-24 for moderate, ≥25 for severe) 3

  2. Document treatment resistance separately in the clinical record, noting:

    • At least two antidepressant trials with <25% improvement 2
    • Adequate dosing and duration (6-8 weeks minimum) 4
    • Documented adherence and proper clinical assessment 2
  3. Consider additional qualifiers in clinical documentation (though not part of the ICD-10 code itself):

    • Presence of melancholic features
    • Anxiety symptoms
    • Seasonal pattern 5

Clinical Pitfalls to Avoid

  • Do not use F33.8 (other recurrent depressive disorders) or F33.9 (unspecified) when severity can be determined—these are less specific and clinically less useful
  • Do not confuse recurrent episodes with bipolar depression—bipolar depression presents more severely and more often with psychotic features 6
  • Do not code based on treatment history alone—the code reflects current episode severity, not treatment response 1

Practical Application

For a patient with recurrent MDD, moderate-to-severe current episode, who has failed adequate trials of two antidepressants:

  • Code F33.1 if HAM-D score 18-24 or moderate functional impairment
  • Code F33.2 if HAM-D score ≥25 or severe functional impairment without psychosis
  • Add clinical documentation noting TRD status and need for treatment modification per ACP guidelines 4

The treatment-resistant status should trigger clinical action (switching, augmentation, or adding CBT) per guidelines 4, 7, but does not alter the diagnostic code itself.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.